Chronic pelvic pain syndrome and the overactive bladder: The inflammatory link

Current Urology Reports

Volumn 9, Issue 4, 2008, Pages 314-319

  Saini, Rajiv ^a   Gonzalez, Ricardo R ^b   Te, Alexis E ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYLGLYCYL DEXTRO TYROSINAMIDE; LOXOPROFEN;

CHRONIC PROSTATITIS; CROSS ALLERGY; CYSTALGIA; CYTOKINE PRODUCTION; DISEASE SEVERITY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INTERSTITIAL CYSTITIS; MAST CELL; NONHUMAN; OVERACTIVE BLADDER; PAINFUL BLADDER SYNDROME; PATHOPHYSIOLOGY; PELVIS PAIN SYNDROME; PERIPHERAL NERVOUS SYSTEM; REVIEW; T LYMPHOCYTE;

CYTOKINES; HUMANS; INFLAMMATION; MALE; PROSTATITIS; URINARY BLADDER, OVERACTIVE;

EID: 48749117302     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-008-0054-8     Document Type: Review

References (50)

1. Wenninger K, Heiman JR, Rothman I, et al.: Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 1996, 155:965-968.
2. Oppenheim J, Feldman M: Cytokine Reference. San Diego: Academic Press; 2001.
3. Jacob CO, McDevitt HO: Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature 1988, 331:356-358.
4. Roitt I, Brostoff J, Male D: Immunology, edn 4. Philadelphia: Lippincott-Raven; 1996.
5. Krieger JN, Nyberg L Jr, Nickel JC: NIH consensus definition and classification of prostatitis. JAMA 1999, 282:236-237.
6. Nickel JC: Prostatitis and related conditions. In Campbell's Urology, edn 8. Edited by Walsh PC, Retik AB, Vaughan ED, et al. Philadelphia: WB Saunders; 2002:603-630.
7. Schaeffer AJ, Knauss JS, Landis JR, et al.: Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002, 168:1048-1053.
8. Schaeffer AJ, Landis JR, Knauss JS, et al.: Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002, 168:593-598.
9. Pontari MA, Ruggieri MR: Mechanisms in prostatitis/ chronic pelvic pain syndrome. J Urol 2004, 172:839-845.
10. Moon TD, Hagen L, Heisey DM: Urinary symptomatology in younger men. Urology 1997, 50:700-703.
11. Naber KG, Weidner W: Chronic prostatitis: an infectious disease? J Antimicrob Chemother 2000, 46:157-161.
12. Alexander RB, Brady F, Ponniah S: Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. Urology 1997, 50:893-899.
13. John H, Maake C, Barghorn A, et al.: Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity. Andrologia 2003, 35:294-299.
14. Nickel JC, Alexander RB, Schaeffer AJ, et al.: Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003, 170:818-822.
15. Nadler RB, Koch AE, Calhoun EA, et al.: IL-lbeta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 2000, 164:214-218.
16. Hochreiter WW, Nadler RB, Koch AE, et al.: Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000, 56:1025-1029.
17. Shahed AR, Shoskes DA: Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol /2001, 166:1738-1741.
18. Alexander RB, Ponniah S, Hasday J, Hebel JR: Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 1998, 52:744-749.
19. Orhan I, Onur R, Ilhan N, Ardicoglu A: Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome. Int J Urol 2001, 8:495-499.
20. Miller LJ, Fischer KA, Goralnick SJ, et al.: Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol 2002, 167(2 Pt l):753-756.
21. Miller LJ, Fischer KA, Goralnick SJ, et al.: Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002, 59:603-608.
22. Penna G, Mondaini N, Amuchastegui S, et al.: Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol 2007, 51:524-533.
23. Elkayam O, Yaron I, Shirazi I, et al.: Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 2000, 19:101-105.
24. Straub RH, Herfarth HH, Rinkes B, et al.: Favorable role of interleukin 10 in patients with polymyalgia rheumatica. J Rheumatol 1999, 26:1318-1325.
25. Khadra A, Fletcher P, Luzzi G, et al.: Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis. BJU Int 2006, 97:1043-1046.
26. Tyagi S, Thomas CA, Hayashi Y, Chancellor MB: The overactive bladder: epidemiology and morbidity. Urol Clin North Am 2006, 33:433-438, vii.
27. Galvin DJ, Watson RW, Gillespie JI, et al.: Mechanical stretch regulates cell survival in human bladder smooth muscle cells in vitro. Am J Physiol Renal Physiol 2002, 283: F1192-F1199.
28. Hanno P: Interstitial cystitis and related disorders. In Campbell's Urology, edn 8. Edited by Walsh PC, Retik AB, Vaughan ED, et al. Philadelphia: WB Saunders; 2002:631-670.
29. Jones CA, Nyberg L: Epidemiology of interstitial cystitis. Urology 1997, 49(5A Suppl):2-9.
30. Elbadawi A: Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 1997, 49(5A Suppl):14-40.
31. Sant GR, Theoharides TC: The role of the mast cell in interstitial cystitis. Urol Clin North Am 1994, 21:41-53.
32. Felsen D, Frye S, Trimble LA, et al.: Inflammatory mediator profile in urine and bladder wash fluid of patients with interstitial cystitis. J Urol 1994, 152(2 Pt 1): 355-361.
33. Lamale LM, Lutgendorf SK, Zimmerman MB, Kreder KJ: Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis. Urology 2006, 68:702-706.
34. Moldwin RM: Similarities between interstitial cystitis and male chronic pelvic pain syndrome. Curr Urol Rep 2002, 3:313-318.
35. Driscoll A, Teichman JM: How do patients with interstitial cystitis present? J Urol 2001, 166:2118-2120.
36. Parsons CL, Albo M: Intravesical potassium sensitivity in patients with prostatitis. J Urol 2002, 168:1054-1057.
37. Yilmaz U, Liu YW, Rothman I, et al.: Intravesical potassium chloride sensitivity test in men with chronic pelvic pain syndrome. J Urol 2004, 172:548-550.
38. Keay S, Zhang CO, Chai T, et al.: Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 2004, 63:22-26.
39. Dupont MC, Spitsbergen JM, Kim KB, et al.: Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 2001, 166:1111-1118.
40. Pezzone M, King W, Fraser A: Bi-directional, cross-sensi-tization of the urinary bladder and distal colon of the rat [AUA abstract]. J Urol 2003, 169(Suppl):260.
41. Saban MR, Saban R, Hammond TG, et al.: LPS-sensory peptide communication in experimental cystitis. Am J Physiol Renal Physiol 2002, 282:F202-F210.
42. Saban R, Gerard NP, Saban MR, et al.: Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism. Am J Physiol Renal Physiol 2002, 283:F616-F629.
43. Batler RA, Sengupta S, Forrestal SG, et al.: Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha. J Urol 2002, 168:819-825.
44. Bjorling DE, Jerde TJ, Zine MJ, et al.: Mast cells mediate the severity of experimental cystitis in mice. J Urol 1999, 162:231-236.
45. Saban MR, Nguyen NB, Hammond TG, Saban R: Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am J Pathol 2002, 160:2095-2110.
46. Saban R, Saban MR, Nguyen NB, et al.: Mast cell regulation of inflammation and gene expression during antigen-induced bladder inflammation in mice. Physiol Genomics 2001, 7:35-43.
47. Lowe EM, Anand P, Terenghi G, et al.: Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997, 79:572-577.
48. Jang J, Park EY, Seo SI, et al.: Effects of intravesical instillation of cyclooxygenase-2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide-induced overactive bladder. BJU Int 2006, 98:435-439.
49. Saito M, Kawatani M, Kinoshita Y, et al.: Effectiveness of an anti-inflammatory drug, loxoprofen, for patients with nocturia. Int J Urol 2005, 12:779-782.
50. Gonzalez RR, Fong T, Belmar N, et al.: Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis. J Urol 2005, 173:630-634.